Pacer Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.23M | Sell |
11,039
-13,429
| -55% | -$4.41M | 0.01% | 749 |
|
|
2025
Q4 | $8.58M | Sell |
24,468
-1,241
| -5% | -$419K | 0.02% | 529 |
|
|
2025
Q3 | $8.31M | Buy |
25,709
+6,711
| +35% | +$2.09M | 0.02% | 529 |
|
|
2025
Q2 | $7.39M | Buy |
18,998
+7,121
| +60% | +$2.86M | 0.02% | 580 |
|
|
2025
Q1 | $5.17M | Sell |
11,877
-16,960
| -59% | -$6.81M | 0.01% | 625 |
|
|
2024
Q4 | $10.6M | Buy |
28,837
+4,249
| +17% | +$1.78M | 0.02% | 445 |
|
|
2024
Q3 | $12.8M | Buy |
24,588
+7,641
| +45% | +$4.08M | 0.03% | 410 |
|
|
2024
Q2 | $9.18M | Sell |
16,947
-999
| -6% | -$528K | 0.02% | 452 |
|
|
2024
Q1 | $9.31M | Buy |
17,946
+2,720
| +18% | +$1.35M | 0.02% | 441 |
|
|
2023
Q4 | $7.18M | Sell |
15,226
-782
| -5% | -$362K | 0.02% | 483 |
|
|
2023
Q3 | $6.97M | Buy |
16,008
+246
| +2% | +$112K | 0.03% | 390 |
|
|
2023
Q2 | $7M | Buy |
15,762
+1,135
| +8% | +$524K | 0.03% | 465 |
|
|
2023
Q1 | $6.73M | Buy |
14,627
+13,788
| +1,643% | +$6.56M | 0.03% | 499 |
|
|
2022
Q4 | $430K | Sell |
839
-848
| -50% | -$431K | ﹤0.01% | 1380 |
|
|
2022
Q3 | $766K | Buy |
1,687
+89
| +6% | +$42.6K | 0.01% | 618 |
|
|
2022
Q2 | $771K | Sell |
1,598
-19,278
| -92% | -$9.54M | 0.01% | 601 |
|
|
2022
Q1 | $10.3M | Buy |
20,876
+8,252
| +65% | +$3.77M | 0.08% | 240 |
|
|
2021
Q4 | $5.85M | Sell |
12,624
-2,008
| -14% | -$845K | 0.06% | 283 |
|
|
2021
Q3 | $5.46M | Sell |
14,632
-1,650
| -10% | -$627K | 0.07% | 342 |
|
|
2021
Q2 | $6.22M | Buy |
16,282
+2,855
| +21% | +$1.09M | 0.09% | 298 |
|
|
2021
Q1 | $4.82M | Sell |
13,427
-411
| -3% | -$132K | 0.08% | 254 |
|
|
2020
Q4 | $4.44M | Sell |
13,838
-6,338
| -31% | -$1.95M | 0.08% | 204 |
|
|
2020
Q3 | $5.42M | Sell |
20,176
-3,020
| -13% | -$813K | 0.12% | 139 |
|
|
2020
Q2 | $6.1M | Buy |
+23,196
| New | +$6.19M | 0.12% | 131 |
|
|
2020
Q1 | – | Sell |
-29,007
| Closed | -$8.76M | – | 801 |
|
|
2019
Q4 | $8.76M | Buy |
29,007
+967
| +3% | +$266K | 0.4% | 31 |
|
|
2019
Q3 | $6.73M | Buy |
28,040
+2,961
| +12% | +$811K | 0.15% | 120 |
|
|
2019
Q2 | $7.08M | Buy |
25,079
+1,987
| +9% | +$543K | 0.17% | 95 |
|
|
2019
Q1 | $6.63M | Buy |
+23,092
| New | +$6.68M | 0.18% | 94 |
|
|
2018
Q4 | – | Sell |
-14,025
| Closed | -$3.84M | – | 696 |
|
|
2018
Q3 | $3.84M | Buy |
14,025
+2,151
| +18% | +$558K | 0.14% | 126 |
|
|
2018
Q2 | $2.83M | Buy |
11,874
+1,984
| +20% | +$459K | 0.13% | 155 |
|
|
2018
Q1 | $2.17M | Buy |
9,890
+162
| +2% | +$38.1K | 0.12% | 174 |
|
|
2017
Q4 | $2.19M | Buy |
9,728
+1,807
| +23% | +$385K | 0.15% | 127 |
|
|
2017
Q3 | $1.5M | Buy |
7,921
+387
| +5% | +$73.7K | 0.13% | 134 |
|
|
2017
Q2 | $1.42M | Buy |
7,534
+362
| +5% | +$65K | 0.14% | 123 |
|
|
2017
Q1 | $1.19M | Buy |
7,172
+176
| +3% | +$28K | 0.15% | 112 |
|
|
2016
Q4 | $1M | Buy |
6,996
+1,591
| +29% | +$213K | 0.14% | 113 |
|
|
2016
Q3 | $677K | Sell |
5,405
-32
| -0.6% | -$4.13K | 0.1% | 226 |
|
|
2016
Q2 | $714K | Sell |
5,437
-905
| -14% | -$124K | 0.11% | 182 |
|
|
2016
Q1 | $881K | Sell |
6,342
-240
| -4% | -$32.1K | 0.2% | 101 |
|
|
2015
Q4 | $917K | Buy |
6,582
+4,728
| +255% | +$651K | 0.22% | 95 |
|
|
2015
Q3 | $260K | Hold |
1,854
| – | – | 0.63% | 70 |
|
|
2015
Q2 | $304K | Hold |
1,854
| – | – | 0.63% | 59 |
|
|
2015
Q1 | $286K | Buy |
+1,854
| New | +$264K | 0.59% | 65 |
|
|
2013
Q4 | $1.64M | Buy |
+13,056
| New | +$1.16M | 0.39% | 60 |
|
Other funds holding ELV
VCM
VPM
Pacer Advisors's ELV Position: Q1 2026 in Review
Pacer Advisors reduced its Elevance Health (ELV) stake by 55% in Q1 2026, selling an estimated $4.41M and leaving 11,039 shares worth $3.23M. The position accounts for 0.01% of the portfolio, ranked #749.
Pacer Advisors first reported a position in ELV in Q4 2013 and has held it in 44 quarters since. The position peaked at $12.8M in Q3 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Pacer Advisors held 11,039 shares of Elevance Health worth $3.23M as of Q1 2026.
- Pacer Advisors sold 13,429 Elevance Health shares in Q1 2026, an estimated $4.41M.
- Elevance Health made up 0.01% of Pacer Advisors's portfolio in Q1 2026, its #749 holding.
- Pacer Advisors first reported a position in Elevance Health in Q4 2013 and has held it in 44 quarters since.
- Pacer Advisors's Elevance Health position peaked at $12.8M in Q3 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.